<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32031074</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1875-6190</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>10</Issue><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Current neuropharmacology</Title><ISOAbbreviation>Curr Neuropharmacol</ISOAbbreviation></Journal><ArticleTitle>Role of Nuclear Factor Kappa B (NF-&#x3ba;B) Signalling in Neurodegenerative Diseases: An Mechanistic Approach.</ArticleTitle><Pagination><StartPage>918</StartPage><EndPage>935</EndPage><MedlinePgn>918-935</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2174/1570159X18666200207120949</ELocationID><Abstract><AbstractText>A transcriptional regulatory nuclear factor kappa B (NF-&#x3ba;B) protein is a modulator of cellular biological activity via binding to a promoter region in the nucleus and transcribing various protein genes. The recent research implicated the intensive role of nuclear factor kappa B (NF-&#x3ba;B) in diseases like autoimmune disorder, inflammatory, cardiovascular and neurodegenerative diseases. Therefore, targeting the nuclear factor kappa B (NF-&#x3ba;B) protein offers a new opportunity as a therapeutic approach. Activation of I&#x3ba;B kinase/NF-&#x3ba;B signaling pathway leads to the development of various pathological conditions in human beings, such as neurodegenerative, inflammatory disorders, autoimmune diseases, and cancer. Therefore, the transcriptional activity of I&#x3ba;B kinase/NF- &#x3ba;B is strongly regulated at various cascade pathways. The nuclear factor NF-kB pathway plays a major role in the expression of pro-inflammatory genes, including cytokines, chemokines, and adhesion molecules. In response to the diverse stimuli, the cytosolic sequestered NF-&#x3ba;B in an inactivated form by binding with an inhibitor molecule protein (IkB) gets phosphorylated and translocated into the nucleus further transcribing various genes necessary for modifying various cellular functions. The various researches confirmed the role of different family member proteins of NF-&#x3ba;B implicated in expressing various genes products and mediating various cellular cascades. MicroRNAs, as regulators of NF- &#x3ba;B microRNAs play important roles in the regulation of the inflammatory process. Therefore, the inhibitor of NF-&#x3ba;B and its family members plays a novel therapeutic target in preventing various diseases. Regulation of NF- &#x3ba;B signaling pathway may be a safe and effective treatment strategy for various disorders.</AbstractText><CopyrightInformation>Copyright&#xa9; Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Shareen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Chitkara College of Pharmacy, Chitkara University, Punjab, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Thakur Gurjeet</ForeName><Initials>TG</Initials><AffiliationInfo><Affiliation>Chitkara College of Pharmacy, Chitkara University, Punjab, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United Arab Emirates</Country><MedlineTA>Curr Neuropharmacol</MedlineTA><NlmUniqueID>101157239</NlmUniqueID><ISSNLinking>1570-159X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000070642" MajorTopicYN="N">Brain Injuries, Traumatic</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002545" MajorTopicYN="N">Brain Ischemia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004827" MajorTopicYN="N">Epilepsy</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="N">Huntington Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017096" MajorTopicYN="N">Prion Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020754" MajorTopicYN="N">Spinocerebellar Ataxias</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">MicroRNAs</Keyword><Keyword MajorTopicYN="N">Transcriptional</Keyword><Keyword MajorTopicYN="N">autoimmune diseases</Keyword><Keyword MajorTopicYN="N">inflammatory
disorders</Keyword><Keyword MajorTopicYN="N">neurodegenerative</Keyword><Keyword MajorTopicYN="N">nuclear factor kappa B (NF-&#x3ba;B)</Keyword><Keyword MajorTopicYN="N">pro-inflammatory genes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>1</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32031074</ArticleId><ArticleId IdType="pmc">PMC7709146</ArticleId><ArticleId IdType="doi">10.2174/1570159X18666200207120949</ArticleId><ArticleId IdType="pii">CN-EPUB-104315</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Qin Z.H., Tao L.Y., Chen X. Dual roles of NF-kappaB in cell survival and implications of NF-kappaB inhibitors in neuroprotective therapy. Acta Pharmacol. Sin. 2007;28(12):1859&#x2013;1872. doi: 10.1111/j.1745-7254.2007.00741.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1745-7254.2007.00741.x</ArticleId><ArticleId IdType="pubmed">18031598</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C.H., Zhou W., Liu S., Deng Y., Cai F., Tone M., Tone Y., Tong Y., Song W. Increased NF-KB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer&#x2019;s disease. Int. J. Neuropsychopharmacol. 2012;15(1):77&#x2013;90. doi: 10.1017/S1461145711000149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1461145711000149</ArticleId><ArticleId IdType="pubmed">21329555</ArticleId></ArticleIdList></Reference><Reference><Citation>Camandola S., Mattson M.P. NF-&#x3ba; B as a therapeutic target in neurodegenerative diseases. Expert Opin. Ther. Targets. 2007;11(2):123&#x2013;132. doi: 10.1517/14728222.11.2.123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14728222.11.2.123</ArticleId><ArticleId IdType="pubmed">17227229</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaltschmidt B., Baeuerle P.A., Kaltschmidt C. Potential involvement of the transcription factor NF-&#x3ba; B in neurological disorders. Mol. Aspects Med. 1993;14(3):171&#x2013;190. doi: 10.1016/0098-2997(93)90004-W.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0098-2997(93)90004-W</ArticleId><ArticleId IdType="pubmed">8264332</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Neill L.A., Kaltschmidt C. NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 1997;20(6):252&#x2013;258. doi: 10.1016/S0166-2236(96)01035-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0166-2236(96)01035-1</ArticleId><ArticleId IdType="pubmed">9185306</ArticleId></ArticleIdList></Reference><Reference><Citation>Thanos D., Maniatis T. NF-&#x3ba; B: a lesson in family values. Cell. 1995;80(4):529&#x2013;532. doi: 10.1016/0092-8674(95)90506-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(95)90506-5</ArticleId><ArticleId IdType="pubmed">7867060</ArticleId></ArticleIdList></Reference><Reference><Citation>Karin M. How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene. 1999;18(49):6867&#x2013;6874. doi: 10.1038/sj.onc.1203219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1203219</ArticleId><ArticleId IdType="pubmed">10602462</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi P., Aggarwal A. NF-kB transcription factor: a key player in the generation of immune response. Curr. Sci. 2006;90(4):519.</Citation></Reference><Reference><Citation>Cornwell W.D., Kirkpatrick R.B. Cactus-independent nuclear translocation of Drosophila RELISH. J. Cell. Biochem. 2001;82(1):22&#x2013;37. doi: 10.1002/jcb.1144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.1144</ArticleId><ArticleId IdType="pubmed">11400160</ArticleId></ArticleIdList></Reference><Reference><Citation>Heissmeyer V., Krappmann D., Hatada E.N., Scheidereit C. Shared pathways of IkappaB kinase-induced SCF(betaTrCP)-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and IkappaBalpha. Mol. Cell. Biol. 2001;21(4):1024&#x2013;1035. doi: 10.1128/MCB.21.4.1024-1035.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.21.4.1024-1035.2001</ArticleId><ArticleId IdType="pmc">PMC99557</ArticleId><ArticleId IdType="pubmed">11158290</ArticleId></ArticleIdList></Reference><Reference><Citation>Oeckinghaus A., Ghosh S. The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb. Perspect. Biol. 2009;1(4):a000034. doi: 10.1101/cshperspect.a000034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a000034</ArticleId><ArticleId IdType="pmc">PMC2773619</ArticleId><ArticleId IdType="pubmed">20066092</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Z., Chiao P., Zhang X., Zhang X., Lazar M.A., Seto E., Young H.A., Ye J. Coactivators and corepressors of NF-kappaB in IkappaB alpha gene promoter. J. Biol. Chem. 2005;280(22):21091&#x2013;21098. doi: 10.1074/jbc.M500754200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M500754200</ArticleId><ArticleId IdType="pmc">PMC1237005</ArticleId><ArticleId IdType="pubmed">15811852</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Z., He Q., Peng B., Chiao P., Ye J. Regulation of nuclear translocation of HDAC3 by IkBalpha is required for TNF-inhibition of PPARgamma function. J. Biochem. 2006;281(7):4540&#x2013;4547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1447600</ArticleId><ArticleId IdType="pubmed">16371367</ArticleId></ArticleIdList></Reference><Reference><Citation>Barr&#xe9; B., Perkins N.D. A cell cycle regulatory network controlling NF-kappaB subunit activity and function. EMBO J. 2007;26(23):4841&#x2013;4855. doi: 10.1038/sj.emboj.7601899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.emboj.7601899</ArticleId><ArticleId IdType="pmc">PMC2099464</ArticleId><ArticleId IdType="pubmed">17962807</ArticleId></ArticleIdList></Reference><Reference><Citation>Courtois G., Fauvarque M.O. The many roles of ubiquitin in NF-KB signaling. Biomedicines. 2018;6(2):43. doi: 10.3390/biomedicines6020043.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines6020043</ArticleId><ArticleId IdType="pmc">PMC6027159</ArticleId><ArticleId IdType="pubmed">29642643</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Kang J., Zhang L., Liang Z., Tang X., Yan Y., Qian H., Zhang X., Xu W., Mao F. Ubiquitination regulation of inflammatory responses through NF-KB pathway. Am. J. Transl. Res. 2018;10(3):881&#x2013;891.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5883129</ArticleId><ArticleId IdType="pubmed">29636878</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilmore T.D. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene. 2006;25(51):6680&#x2013;6684. doi: 10.1038/sj.onc.1209954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1209954</ArticleId><ArticleId IdType="pubmed">17072321</ArticleId></ArticleIdList></Reference><Reference><Citation>Perkins N.D. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat. Rev. Mol. Cell Biol. 2007;8(1):49&#x2013;62. doi: 10.1038/nrm2083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm2083</ArticleId><ArticleId IdType="pubmed">17183360</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih R.H., Wang C.Y., Yang C.M. NF-kappaB signaling pathways in neurological inflammation: a mini review. Front. Mol. Neurosci. 2015;8:77. doi: 10.3389/fnmol.2015.00077.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2015.00077</ArticleId><ArticleId IdType="pmc">PMC4683208</ArticleId><ArticleId IdType="pubmed">26733801</ArticleId></ArticleIdList></Reference><Reference><Citation>Kendellen M.F., Bradford J.W., Lawrence C.L., Clark K.S., Baldwin A.S. Canonical and non-canonical NF-KB signaling promotes breast cancer tumor-initiating cells. Oncogene. 2014;33(10):1297&#x2013;1305. doi: 10.1038/onc.2013.64.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/onc.2013.64</ArticleId><ArticleId IdType="pmc">PMC4425414</ArticleId><ArticleId IdType="pubmed">23474754</ArticleId></ArticleIdList></Reference><Reference><Citation>Verstrepen L., Bekaert T., Chau T.L., Tavernier J., Chariot A., Beyaert R. TLR-4, IL-1R and TNF-R signaling to NF-kappaB: variations on a common theme. Cell. Mol. Life Sci. 2008;65(19):2964&#x2013;2978. doi: 10.1007/s00018-008-8064-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-008-8064-8</ArticleId><ArticleId IdType="pubmed">18535784</ArticleId></ArticleIdList></Reference><Reference><Citation>Isra&#xeb;l A. The IKK complex, a central regulator of NF-kappaB activation. Cold Spring Harb. Perspect. Biol. 2010;2(3):a000158. doi: 10.1101/cshperspect.a000158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a000158</ArticleId><ArticleId IdType="pmc">PMC2829958</ArticleId><ArticleId IdType="pubmed">20300203</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma S., De Jesus P., Chanda S.K., Verma I.M. SNW1, a Novel transcriptional regulator of the NF-KB pathway. Mol. Cell. Biol. 2019;39(3):e00415&#x2013;e00418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6336138</ArticleId><ArticleId IdType="pubmed">30397075</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaltschmidt B., Sparna T., Kaltschmidt C. Activation of NF-&#x3ba; B by reactive oxygen intermediates in the nervous system. Antioxid. Redox Signal. 1999;1(2):129&#x2013;144. doi: 10.1089/ars.1999.1.2-129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.1999.1.2-129</ArticleId><ArticleId IdType="pubmed">11228742</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh A., Roy A., Liu X., Kordower J.H., Mufson E.J., Hartley D.M., Ghosh S., Mosley R.L., Gendelman H.E., Pahan K. Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson&#x2019;s disease. Proc. Natl. Acad. Sci. USA. 2007;104(47):18754&#x2013;18759. doi: 10.1073/pnas.0704908104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0704908104</ArticleId><ArticleId IdType="pmc">PMC2141849</ArticleId><ArticleId IdType="pubmed">18000063</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedmann-Morvinski D., Narasimamurthy R., Xia Y., Myskiw C., Soda Y., Verma I.M. Targeting NF-KB in glioblastoma: A therapeutic approach. Sci. Adv. 2016;2(1):e1501292. doi: 10.1126/sciadv.1501292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.1501292</ArticleId><ArticleId IdType="pmc">PMC4730860</ArticleId><ArticleId IdType="pubmed">26824076</ArticleId></ArticleIdList></Reference><Reference><Citation>Negroni A., Pierdomenico M., Cucchiara S., Stronati L. NOD2 and inflammation: current insights. J. Inflamm. Res. 2018;11:49&#x2013;60. doi: 10.2147/JIR.S137606.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S137606</ArticleId><ArticleId IdType="pmc">PMC5813767</ArticleId><ArticleId IdType="pubmed">29483781</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed A.U., Williams B.R., Hannigan G.E. Transcriptional activation of inflammatory genes: mechanistic insight into selectivity and diversity. Biomolecules. 2015;5(4):3087&#x2013;3111. doi: 10.3390/biom5043087.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom5043087</ArticleId><ArticleId IdType="pmc">PMC4693271</ArticleId><ArticleId IdType="pubmed">26569329</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman M.M., McFadden G. Modulation of NF-KB signalling by microbial pathogens. Nat. Rev. Microbiol. 2011;9(4):291&#x2013;306. doi: 10.1038/nrmicro2539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro2539</ArticleId><ArticleId IdType="pmc">PMC3611960</ArticleId><ArticleId IdType="pubmed">21383764</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen F., Demers L.M., Shi X. Upstream signal transduction of NF-kappaB activation. Curr. Drug Targets Inflamm. Allergy. 2002;1(2):137&#x2013;149. doi: 10.2174/1568010023344706.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568010023344706</ArticleId><ArticleId IdType="pubmed">14561196</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaftel S.S., Griffin W.S.T., O&#x2019;Banion M.K. The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective. J. Neuroinflammation. 2008;5(1):7. doi: 10.1186/1742-2094-5-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-5-7</ArticleId><ArticleId IdType="pmc">PMC2335091</ArticleId><ArticleId IdType="pubmed">18302763</ArticleId></ArticleIdList></Reference><Reference><Citation>Stojakovic A., Paz-Filho G., Arcos-Burgos M., Licinio J., Wong M.L., Mastronardi C.A. Role of the IL-1 pathway in dopaminergic neurodegeneration and decreased voluntary movement. Mol. Neurobiol. 2017;54(6):4486&#x2013;4495. doi: 10.1007/s12035-016-9988-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-016-9988-x</ArticleId><ArticleId IdType="pmc">PMC5509814</ArticleId><ArticleId IdType="pubmed">27356916</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia J.M., Stillings S.A., Leclerc J.L., Phillips H., Edwards N.J., Robicsek S.A., Hoh B.L., Blackburn S., Dor&#xe9; S. Role of interleukin-10 in acute brain injuries. Front. Neurol. 2017;8:244. doi: 10.3389/fneur.2017.00244.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2017.00244</ArticleId><ArticleId IdType="pmc">PMC5466968</ArticleId><ArticleId IdType="pubmed">28659854</ArticleId></ArticleIdList></Reference><Reference><Citation>Costantini E., D&#x2019;Angelo C., Reale M. The role of immunosenescence in neurodegenerative diseases. Mediators Inflamm. 2018;2018:6039171. doi: 10.1155/2018/6039171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/6039171</ArticleId><ArticleId IdType="pmc">PMC5863336</ArticleId><ArticleId IdType="pubmed">29706800</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung Y.J., Tweedie D., Scerba M.T., Greig N.H. Neuroinflammation as a factor of neurodegenerative disease: Thalidomide analogs as treatments. Front. Cell Dev. Biol. 2019;7:313. doi: 10.3389/fcell.2019.00313.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2019.00313</ArticleId><ArticleId IdType="pmc">PMC6904283</ArticleId><ArticleId IdType="pubmed">31867326</ArticleId></ArticleIdList></Reference><Reference><Citation>Glass C.K., Saijo K., Winner B., Marchetto M.C., Gage F.H. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010;140(6):918&#x2013;934. doi: 10.1016/j.cell.2010.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.02.016</ArticleId><ArticleId IdType="pmc">PMC2873093</ArticleId><ArticleId IdType="pubmed">20303880</ArticleId></ArticleIdList></Reference><Reference><Citation>Krumbholz M., Theil D., Derfuss T., Rosenwald A., Schrader F., Monoranu C.M., Kalled S.L., Hess D.M., Serafini B., Aloisi F., Wekerle H., Hohlfeld R., Meinl E. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J. Exp. Med. 2005;201(2):195&#x2013;200. doi: 10.1084/jem.20041674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20041674</ArticleId><ArticleId IdType="pmc">PMC2212784</ArticleId><ArticleId IdType="pubmed">15642740</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma L., Li R., Huang H., Yuan J., Ou S., Xu T., Yu X., Liu X., Chen Y. Up-regulated BAFF and BAFF receptor expression in patients with intractable temporal lobe epilepsy and a pilocarpine-induced epilepsy rat model. Seizure. 2017;48:79&#x2013;88. doi: 10.1016/j.seizure.2017.03.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.seizure.2017.03.016</ArticleId><ArticleId IdType="pubmed">28441631</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Dea E.L., Kearns J.D., Hoffmann A. UV as an amplifier rather than inducer of NF-kappaB activity. Mol. Cell. 2008;30(5):632&#x2013;641. doi: 10.1016/j.molcel.2008.03.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2008.03.017</ArticleId><ArticleId IdType="pmc">PMC2682114</ArticleId><ArticleId IdType="pubmed">18538661</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma A., Kushwaha H.N., Srivastava A.K., Srivastava S., Jamal N., Srivastava K., Ray R.S. Piperine attenuates UV-R induced cell damage in human keratinocytes via NF-kB, Bax/Bcl-2 pathway: An application for photoprotection. J. Photochem. Photobiol. B. 2017;172:139&#x2013;148. doi: 10.1016/j.jphotobiol.2017.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jphotobiol.2017.05.018</ArticleId><ArticleId IdType="pubmed">28550736</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L., Hui L., Zhang Z.Z. 2011.</Citation></Reference><Reference><Citation>Begum N., Wang B., Mori M., Vares G. Does ionizing radiation influence Alzheimer&#x2019;s disease risk? J. Radiat. Res. (Tokyo) 2012;53(6):815&#x2013;822. doi: 10.1093/jrr/rrs036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jrr/rrs036</ArticleId><ArticleId IdType="pmc">PMC3483841</ArticleId><ArticleId IdType="pubmed">22872779</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Jiao Q., Xu H., Du X., Shi L., Jia F., Jiang H. Biometal dyshomeostasis and toxic metal accumulations in the development of Alzheimer&#x2019;s disease. Front. Mol. Neurosci. 2017;10:339. doi: 10.3389/fnmol.2017.00339.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00339</ArticleId><ArticleId IdType="pmc">PMC5660707</ArticleId><ArticleId IdType="pubmed">29114205</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Wang X., Vikash V., Ye Q., Wu D., Liu Y., Dong W. ROS and ROS-mediated cellular signaling. Oxid. Med. Cell. Longev. 2016;2016:4350965. doi: 10.1155/2016/4350965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/4350965</ArticleId><ArticleId IdType="pmc">PMC4779832</ArticleId><ArticleId IdType="pubmed">26998193</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J., Nan G. The extracellular signal-regulated kinase 1/2 pathway in neurological diseases: A potential therapeutic target. Int. J. Mol. Med. 2017;39(6):1338&#x2013;1346. doi: 10.3892/ijmm.2017.2962. [Review].</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2017.2962</ArticleId><ArticleId IdType="pmc">PMC5428947</ArticleId><ArticleId IdType="pubmed">28440493</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.K., Kim N.J. Recent advances in the inhibition of p38 MAPK as a potential strategy for the treatment of Alzheimer&#x2019;s disease. Molecules. 2017;22(8):1287. doi: 10.3390/molecules22081287.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules22081287</ArticleId><ArticleId IdType="pmc">PMC6152076</ArticleId><ArticleId IdType="pubmed">28767069</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi C., Park J.Y., Lee J., Lim J.H., Shin E.C., Ahn Y.S., Kim C.H., Kim S.J., Kim J.D., Choi I.S., Choi I.H. Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-&#x3b1;, or IFN-&#x3b3;. J. Immunol. 1999;162(4):1889&#x2013;1895.</Citation><ArticleIdList><ArticleId IdType="pubmed">9973455</ArticleId></ArticleIdList></Reference><Reference><Citation>Vuong B., Hogan-Cann A.D., Alano C.C., Stevenson M., Chan W.Y., Anderson C.M., Swanson R.A., Kauppinen T.M. NF-KB transcriptional activation by TNF&#x3b1; requires phospholipase C, extracellular signal-regulated kinase 2 and poly(ADP-ribose) polymerase-1. J. Neuroinflammation. 2015;12(1):229. doi: 10.1186/s12974-015-0448-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-015-0448-8</ArticleId><ArticleId IdType="pmc">PMC4670503</ArticleId><ArticleId IdType="pubmed">26637332</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin D., Woodruff M., Zhang Y., Whaley S., Miao J., Ferslew K., Zhao J., Stuart C. Morphine promotes Jurkat cell apoptosis through pro-apoptotic FADD/P53 and anti-apoptotic PI3K/Akt/NF-kappaB pathways. J. Neuroimmunol. 2006;174(1-2):101&#x2013;107. doi: 10.1016/j.jneuroim.2006.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2006.02.001</ArticleId><ArticleId IdType="pubmed">16529824</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Tao L.Y., Chen X.P. Roles of NF-kappaB in central nervous system damage and repair. Neurosci. Bull. 2007;23(5):307&#x2013;313. doi: 10.1007/s12264-007-0046-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12264-007-0046-6</ArticleId><ArticleId IdType="pmc">PMC5550580</ArticleId><ArticleId IdType="pubmed">17952141</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinaci M.K., Erkasap N., Kucuk A., Koken T., Tosun M. Effects of quercetin on apoptosis, NF-KB and NOS gene expression in renal ischemia/reperfusion injury. Exp. Ther. Med. 2012;3(2):249&#x2013;254. doi: 10.3892/etm.2011.382.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2011.382</ArticleId><ArticleId IdType="pmc">PMC3438559</ArticleId><ArticleId IdType="pubmed">22969877</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia G., Zhang Y., Li W., Dai H. Neuroprotective role of icariin in experimental spinal cord injury via its antioxidant, anti-neuroinflammatory and anti-apoptotic properties. Mol. Med. Rep. 2019;20(4):3433&#x2013;3439. doi: 10.3892/mmr.2019.10537.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2019.10537</ArticleId><ArticleId IdType="pubmed">31432160</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez H., Hale V.A., Dolcet X., Davies A. NF-kappaB signalling regulates the growth of neural processes in the developing PNS and CNS. Development. 2005;132(7):1713&#x2013;1726. doi: 10.1242/dev.01702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.01702</ArticleId><ArticleId IdType="pubmed">15743881</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez H., Davies A.M. Regulation of neural process growth, elaboration and structural plasticity by NF-KB. Trends Neurosci. 2011;34(6):316&#x2013;325. doi: 10.1016/j.tins.2011.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2011.03.001</ArticleId><ArticleId IdType="pmc">PMC3115056</ArticleId><ArticleId IdType="pubmed">21459462</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattson M.P., Camandola S. NF-kappaB in neuronal plasticity and neurodegenerative disorders. J. Clin. Invest. 2001;107(3):247&#x2013;254. doi: 10.1172/JCI11916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI11916</ArticleId><ArticleId IdType="pmc">PMC199201</ArticleId><ArticleId IdType="pubmed">11160145</ArticleId></ArticleIdList></Reference><Reference><Citation>Mincheva-Tasheva S., Soler R.M. NF-KB signaling pathways: role in nervous system physiology and pathology. Neuroscientist. 2013;19(2):175&#x2013;194. doi: 10.1177/1073858412444007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073858412444007</ArticleId><ArticleId IdType="pubmed">22785105</ArticleId></ArticleIdList></Reference><Reference><Citation>Snow W.M., Albensi B.C. Neuronal gene targets of NF-KB and their dysregulation in Alzheimer&#x2019;s disease. Front. Mol. Neurosci. 2016;9:118. doi: 10.3389/fnmol.2016.00118.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2016.00118</ArticleId><ArticleId IdType="pmc">PMC5101203</ArticleId><ArticleId IdType="pubmed">27881951</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelmann C., Weih F., Haenold R. Role of nuclear factor kappa B in central nervous system regeneration. Neural Regen. Res. 2014;9(7):707&#x2013;711. doi: 10.4103/1673-5374.131572.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.131572</ArticleId><ArticleId IdType="pmc">PMC4146279</ArticleId><ArticleId IdType="pubmed">25206877</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattson M.P., Meffert M.K. Roles for NF-kappaB in nerve cell survival, plasticity, and disease. Cell Death Differ. 2006;13(5):852&#x2013;860. doi: 10.1038/sj.cdd.4401837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.cdd.4401837</ArticleId><ArticleId IdType="pubmed">16397579</ArticleId></ArticleIdList></Reference><Reference><Citation>Dresselhaus E.C., Meffert M.K. Cellular specificity of NF-kappaB function in the nervous system. Front. Immunol. 2019;10:1043. doi: 10.3389/fimmu.2019.01043.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01043</ArticleId><ArticleId IdType="pmc">PMC6520659</ArticleId><ArticleId IdType="pubmed">31143184</ArticleId></ArticleIdList></Reference><Reference><Citation>Motyl J., Strosznajder J.B. Sphingosine kinase 1/sphingosine-1-phosphate receptors dependent signalling in neurodegenerative diseases. The promising target for neuroprotection in Parkinson&#x2019;s disease. Pharmacol. Rep. 2018;70(5):1010&#x2013;1014. doi: 10.1016/j.pharep.2018.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharep.2018.05.002</ArticleId><ArticleId IdType="pubmed">30138818</ArticleId></ArticleIdList></Reference><Reference><Citation>Strozyk E., Kulms D. NFKB: cell survival or cell death? Signal Transduct. 2005;5(6):334&#x2013;349. doi: 10.1002/sita.200500070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sita.200500070</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozniak P.D., White M.K., Khalili K. TNF-&#x3b1;/NF-KB signaling in the CNS: possible connection to EPHB2. J. Neuroimmune Pharmacol. 2014;9(2):133&#x2013;141. doi: 10.1007/s11481-013-9517-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-013-9517-x</ArticleId><ArticleId IdType="pmc">PMC3959244</ArticleId><ArticleId IdType="pubmed">24277482</ArticleId></ArticleIdList></Reference><Reference><Citation>Sedger L.M., McDermott M.F. TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants - past, present and future. Cytokine Growth Factor Rev. 2014;25(4):453&#x2013;472. doi: 10.1016/j.cytogfr.2014.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2014.07.016</ArticleId><ArticleId IdType="pubmed">25169849</ArticleId></ArticleIdList></Reference><Reference><Citation>Karin M., Lin A. NF-kappaB at the crossroads of life and death. Nat. Immunol. 2002;3(3):221&#x2013;227. doi: 10.1038/ni0302-221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni0302-221</ArticleId><ArticleId IdType="pubmed">11875461</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi J., Luo J. SIRT1 and p53, effect on cancer, senescence and beyond. Biochim. Biophys. Acta. 2010;1804(8):1684&#x2013;1689. doi: 10.1016/j.bbapap.2010.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbapap.2010.05.002</ArticleId><ArticleId IdType="pmc">PMC2989880</ArticleId><ArticleId IdType="pubmed">20471503</ArticleId></ArticleIdList></Reference><Reference><Citation>Nkpaa K.W., Adedara I.A., Amadi B.A., Wegwu M.O., Farombi E.O. Ethanol via Regulation of NF-KB/p53 Signaling Pathway Increases Manganese-Induced Inflammation and Apoptosis in Hypothalamus of Rats. Biol. Trace Elem. Res. 2019;190(1):101&#x2013;108. doi: 10.1007/s12011-018-1535-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12011-018-1535-3</ArticleId><ArticleId IdType="pubmed">30284675</ArticleId></ArticleIdList></Reference><Reference><Citation>Park A., Koh H.C. NF-KB/mTOR-mediated autophagy can regulate diquat-induced apoptosis. Arch. Toxicol. 2019;93(5):1239&#x2013;1253. doi: 10.1007/s00204-019-02424-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00204-019-02424-7</ArticleId><ArticleId IdType="pubmed">30848314</ArticleId></ArticleIdList></Reference><Reference><Citation>Pourhanifeh M.H., Shafabakhsh R., Reiter R.J., Asemi Z. The Effect of resveratrol on neurodegenerative disorders: possible protective actions against autophagy, apoptosis, inflammation and oxidative stress. Curr. Pharm. Des. 2019;25(19):2178&#x2013;2191. doi: 10.2174/1381612825666190717110932.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612825666190717110932</ArticleId><ArticleId IdType="pubmed">31333112</ArticleId></ArticleIdList></Reference><Reference><Citation>Culmsee C., Mattson M.P. p53 in neuronal apoptosis. Biochem. Biophys. Res. Commun. 2005;331(3):761&#x2013;777. doi: 10.1016/j.bbrc.2005.03.149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2005.03.149</ArticleId><ArticleId IdType="pubmed">15865932</ArticleId></ArticleIdList></Reference><Reference><Citation>Grilli M., Memo M. Possible role of NF-kappaB and p53 in the glutamate-induced pro-apoptotic neuronal pathway. Cell Death Differ. 1999;6(1):22&#x2013;27. doi: 10.1038/sj.cdd.4400463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.cdd.4400463</ArticleId><ArticleId IdType="pubmed">10200544</ArticleId></ArticleIdList></Reference><Reference><Citation>Karova K., Wainwright J.V., Machova-Urdzikova L., Pisal R.V., Schmidt M., Jendelova P., Jhanwar-Uniyal M. Transplantation of neural precursors generated from spinal progenitor cells reduces inflammation in spinal cord injury via NF-KB pathway inhibition. J. Neuroinflammation. 2019;16(1):12. doi: 10.1186/s12974-019-1394-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-019-1394-7</ArticleId><ArticleId IdType="pmc">PMC6335809</ArticleId><ArticleId IdType="pubmed">30654804</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarbrick S., Wragg N., Ghosh S., Stolzing A. Systematic review of miRNA as biomarkers in Alzheimer&#x2019;s disease. Mol. Neurobiol. 2019;56(9):6156&#x2013;6167. doi: 10.1007/s12035-019-1500-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-1500-y</ArticleId><ArticleId IdType="pmc">PMC6682547</ArticleId><ArticleId IdType="pubmed">30734227</ArticleId></ArticleIdList></Reference><Reference><Citation>Muhammad T., Ikram M., Ullah R., Rehman S.U., Kim M.O. Hesperetin, a citrus flavonoid, attenuates lps-induced neuroinflammation, apoptosis and memory impairments by modulating TLR4/NF-KB signaling. Nutrients. 2019;11(3):648. doi: 10.3390/nu11030648.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11030648</ArticleId><ArticleId IdType="pmc">PMC6471991</ArticleId><ArticleId IdType="pubmed">30884890</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu K., Xie Y.Y., Zhang C., Ouyang D.S., Long H.Y., Sun D.N., Long L.L., Feng L., Li Y., Xiao B. MicroRNA expression profile of the hippocampus in a rat model of temporal lobe epilepsy and miR-34a-targeted neuroprotection against hippocampal neurone cell apoptosis post-status epilepticus. BMC Neurosci. 2012;13(1):115. doi: 10.1186/1471-2202-13-115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2202-13-115</ArticleId><ArticleId IdType="pmc">PMC3471047</ArticleId><ArticleId IdType="pubmed">22998082</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y., Deng H., Xu S., Zhang J. MicroRNAs regulate mitochondrial function in cerebral ischemia-reperfusion injury. Int. J. Mol. Sci. 2015;16(10):24895&#x2013;24917. doi: 10.3390/ijms161024895.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms161024895</ArticleId><ArticleId IdType="pmc">PMC4632781</ArticleId><ArticleId IdType="pubmed">26492239</ArticleId></ArticleIdList></Reference><Reference><Citation>Savari F., Badavi M., Rezaie A., Gharib-Naseri M.K., Mard S.A. Evaluation of the therapeutic potential effect of Fas receptor gene knockdown in experimental model of non-alcoholic steatohepatitis. Free Radic. Res. 2019;53(5):486&#x2013;496. doi: 10.1080/10715762.2019.1608982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10715762.2019.1608982</ArticleId><ArticleId IdType="pubmed">31010354</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempuraj D., Thangavel R., Natteru P.A., Selvakumar G.P., Saeed D., Zahoor H., Zaheer S., Iyer S.S., Zaheer A. Neuroinflammation induces neurodegeneration. J. Neurol Neurosurg. Spine. 2016;1(1):1003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5260818</ArticleId><ArticleId IdType="pubmed">28127589</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan D.X., Reiter R.J. Mitochondria: the birth place, battle ground and the site of melatonin metabolism in cells. Melatonin Res. 2019;2(1):44&#x2013;66. doi: 10.32794/mr11250011.</Citation><ArticleIdList><ArticleId IdType="doi">10.32794/mr11250011</ArticleId></ArticleIdList></Reference><Reference><Citation>Borg J., London J. Copper/zinc superoxide dismutase overexpression promotes survival of cortical neurons exposed to neurotoxins in vitro. J. Neurosci. Res. 2002;70(2):180&#x2013;189. doi: 10.1002/jnr.10404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.10404</ArticleId><ArticleId IdType="pubmed">12271467</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L., Guo Y., He P., Xu X., Zhang X., Wang H., Tang T., Zhou W., Xu P., Xie P. Genome-wide profiling of long noncoding RNA expression patterns and CeRNA analysis in mouse cortical neurons infected with different strains of borna disease virus. Genes Dis. 2019;6(2):147&#x2013;158. doi: 10.1016/j.gendis.2019.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gendis.2019.04.002</ArticleId><ArticleId IdType="pmc">PMC6545444</ArticleId><ArticleId IdType="pubmed">31193942</ArticleId></ArticleIdList></Reference><Reference><Citation>Cimmino A., Calin G.A., Fabbri M., Iorio M.V., Ferracin M., Shimizu M., Wojcik S.E., Aqeilan R.I., Zupo S., Dono M., Rassenti L., Alder H., Volinia S., Liu C.G., Kipps T.J., Negrini M., Croce C.M. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. USA. 2005;102(39):13944&#x2013;13949. doi: 10.1073/pnas.0506654102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0506654102</ArticleId><ArticleId IdType="pmc">PMC1236577</ArticleId><ArticleId IdType="pubmed">16166262</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Liu P., Zhu H., Xu Y., Ma C., Dai X., Huang L., Liu Y., Zhang L., Qin C. miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer&#x2019;s disease, inhibits bcl2 translation. Brain Res. Bull. 2009;80(4-5):268&#x2013;273. doi: 10.1016/j.brainresbull.2009.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2009.08.006</ArticleId><ArticleId IdType="pubmed">19683563</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouyang Y.B., Lu Y., Yue S., Giffard R.G. miR-181 targets multiple Bcl-2 family members and influences apoptosis and mitochondrial function in astrocytes. Mitochondrion. 2012;12(2):213&#x2013;219. doi: 10.1016/j.mito.2011.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2011.09.001</ArticleId><ArticleId IdType="pmc">PMC3250561</ArticleId><ArticleId IdType="pubmed">21958558</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q., Xu J., Li L., Li H., Mao S., Zhang F., Zen K., Zhang C.Y., Zhang Q. MicroRNA-23a/b and microRNA-27a/b suppress Apaf-1 protein and alleviate hypoxia-induced neuronal apoptosis. Cell Death Dis. 2014;5(3):e1132. doi: 10.1038/cddis.2014.92.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2014.92</ArticleId><ArticleId IdType="pmc">PMC3973202</ArticleId><ArticleId IdType="pubmed">24651435</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z., Zhang K., Wang Q., Zheng Y. MicroRNA-124 improves functional recovery and suppresses Bax-dependent apoptosis in rats following spinal cord injury. Mol. Med. Rep. 2019;19(4):2551&#x2013;2560. doi: 10.3892/mmr.2019.9904.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2019.9904</ArticleId><ArticleId IdType="pmc">PMC6423616</ArticleId><ArticleId IdType="pubmed">30720072</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokhuis A.M., Groen E.J., Koppers M., van den Berg L.H., Pasterkamp R.J. Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol. 2013;125(6):777&#x2013;794. doi: 10.1007/s00401-013-1125-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1125-6</ArticleId><ArticleId IdType="pmc">PMC3661910</ArticleId><ArticleId IdType="pubmed">23673820</ArticleId></ArticleIdList></Reference><Reference><Citation>Fomin V., Richard P., Hoque M., Li C., Gu Z., Fissore-O&#x2019;Leary M., Tian B., Prives C., Manley J.L. The C9ORF72 gene, implicated in ALS/FTD, encodes a protein that functions in control of endothelin and glutamate signaling. Mol. Cell. Biol. 2018;38(22):e00155&#x2013;e18. doi: 10.1128/MCB.00155-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00155-18</ArticleId><ArticleId IdType="pmc">PMC6206455</ArticleId><ArticleId IdType="pubmed">30150298</ArticleId></ArticleIdList></Reference><Reference><Citation>Casciati A., Ferri A., Cozzolino M., Celsi F., Nencini M., Rotilio G., Carr&#xec; M.T. Oxidative modulation of nuclear factor-kappaB in human cells expressing mutant fALS-typical superoxide dismutases. J. Neurochem. 2002;83(5):1019&#x2013;1029. doi: 10.1046/j.1471-4159.2002.01232.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2002.01232.x</ArticleId><ArticleId IdType="pubmed">12437573</ArticleId></ArticleIdList></Reference><Reference><Citation>Prell T., Lautenschl&#xe4;ger J., Weidemann L., Ruhmer J., Witte O.W., Grosskreutz J. Endoplasmic reticulum stress is accompanied by activation of NF-KB in amyotrophic lateral sclerosis. J. Neuroimmunol. 2014;270(1-2):29&#x2013;36. doi: 10.1016/j.jneuroim.2014.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2014.03.005</ArticleId><ArticleId IdType="pubmed">24666819</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Y., Chen Y. The role of ubiquitinated TDP-43 in amyotrophic lateral sclerosis. Neuroimmunol. Neuroinflamm. 2018;5:5. doi: 10.20517/2347-8659.2017.47.</Citation><ArticleIdList><ArticleId IdType="doi">10.20517/2347-8659.2017.47</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes A.E., Ferraiuolo L., Haidet-Phillips A.M., Schmelzer L., Braun L., Miranda C.J., Ladner K.J., Bevan A.K., Foust K.D., Godbout J.P., Popovich P.G., Guttridge D.C., Kaspar B.K. Microglia induce motor neuron death via the classical NF-KB pathway in amyotrophic lateral sclerosis. Neuron. 2014;81(5):1009&#x2013;1023. doi: 10.1016/j.neuron.2014.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.013</ArticleId><ArticleId IdType="pmc">PMC3978641</ArticleId><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>Cereda C., Gagliardi S., Cova E., Diamanti L., Ceroni M. The role of TNF-Alpha in ALS: new hypotheses for future therapeutic approaches. Amyotroph. Lateral Scler. 2012;&#x2022;&#x2022;&#x2022;:413&#x2013;436.</Citation></Reference><Reference><Citation>Swarup V., Phaneuf D., Dupr&#xe9; N., Petri S., Strong M., Kriz J., Julien J.P. Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor KB-mediated pathogenic pathways. J. Exp. Med. 2011;208(12):2429&#x2013;2447. doi: 10.1084/jem.20111313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20111313</ArticleId><ArticleId IdType="pmc">PMC3256969</ArticleId><ArticleId IdType="pubmed">22084410</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajmone-Cat M.A., Onori A., Toselli C., Stronati E., Morlando M., Bozzoni I., Monni E., Kokaia Z., Lupo G., Minghetti L., Biagioni S., Cacci E. Increased FUS levels in astrocytes leads to astrocyte and microglia activation and neuronal death. Sci. Rep. 2019;9(1):4572. doi: 10.1038/s41598-019-41040-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-41040-4</ArticleId><ArticleId IdType="pmc">PMC6418113</ArticleId><ArticleId IdType="pubmed">30872738</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohta Y., Tremblay C., Schneider J.A., Bennett D.A., Calon F., Julien J.P. Interaction of transactive response DNA binding protein 43 with nuclear factor KB in mild cognitive impairment with episodic memory deficits. Acta Neuropathol. Commun. 2014;2(1):37. doi: 10.1186/2051-5960-2-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2051-5960-2-37</ArticleId><ArticleId IdType="pmc">PMC4230634</ArticleId><ArticleId IdType="pubmed">24690380</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohuchi K., Ono Y., Joho M., Tsuruma K., Ogami S., Yamane S., Funato M., Kaneko H., Nakamura S., Hara H., Shimazawa M. A docosahexaenoic acid-derived pro-resolving agent, Maresin 1, protects motor neuron cells death. Neurochem. Res. 2018;43(7):1413&#x2013;1423. doi: 10.1007/s11064-018-2556-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-018-2556-1</ArticleId><ArticleId IdType="pubmed">29797139</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinchetti P., Rizzuti M., Faravelli I., Corti S. 2018.</Citation></Reference><Reference><Citation>Dardiotis E., Aloizou A.M., Siokas V., Patrinos G.P., Deretzi G., Mitsias P., Aschner M., Tsatsakis A. The role of microRNAs in patients with amyotrophic lateral sclerosis. J. Mol. Neurosci. 2018;66(4):617&#x2013;628. doi: 10.1007/s12031-018-1204-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-018-1204-1</ArticleId><ArticleId IdType="pubmed">30415446</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah S.Z.A., Zhao D., Hussain T., Yang L. The role of unfolded protein response and mitogen-activated protein kinase signaling in neurodegenerative diseases with special focus on prion diseases. Front. Aging Neurosci. 2017;9:120. doi: 10.3389/fnagi.2017.00120.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00120</ArticleId><ArticleId IdType="pmc">PMC5410568</ArticleId><ArticleId IdType="pubmed">28507517</ArticleId></ArticleIdList></Reference><Reference><Citation>Julius C., Heikenwalder M., Schwarz P., Marcel A., Karin M., Prinz M., Pasparakis M., Aguzzi A. Prion propagation in mice lacking central nervous system NF-kappaB signalling. J. Gen. Virol. 2008;89(Pt 6):1545&#x2013;1550. doi: 10.1099/vir.0.83622-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.83622-0</ArticleId><ArticleId IdType="pubmed">18474572</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguzzi A., Nuvolone M., Zhu C. The immunobiology of prion diseases. Nat. Rev. Immunol. 2013;13(12):888&#x2013;902. doi: 10.1038/nri3553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3553</ArticleId><ArticleId IdType="pubmed">24189576</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad K.N., Bondy S.C. Oxidative and inflammatory events in prion diseases: can they be therapeutic targets? Curr. Aging Sci. 2019;11(4):216&#x2013;225. doi: 10.2174/1874609812666190111100205.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1874609812666190111100205</ArticleId><ArticleId IdType="pmc">PMC6635421</ArticleId><ArticleId IdType="pubmed">30636622</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll J.A., Chesebro B. Neuroinflammation, microglia, and cell-association during prion disease. Viruses. 2019;11(1):65. doi: 10.3390/v11010065.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11010065</ArticleId><ArticleId IdType="pmc">PMC6356204</ArticleId><ArticleId IdType="pubmed">30650564</ArticleId></ArticleIdList></Reference><Reference><Citation>Saba R., Goodman C.D., Huzarewich R.L., Robertson C., Booth S.A. A miRNA signature of prion induced neurodegeneration. PLoS One. 2008;3(11):e3652. doi: 10.1371/journal.pone.0003652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0003652</ArticleId><ArticleId IdType="pmc">PMC2575400</ArticleId><ArticleId IdType="pubmed">18987751</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanata E., Th&#xfc;ne K., Xanthopoulos K., Ferrer I., Dafou D., Zerr I., Sklaviadis T., Llorens F. MicroRNA alterations in the brain and body fluids of humans and animal prion disease models: current status and perspectives. Front. Aging Neurosci. 2018;10:220. doi: 10.3389/fnagi.2018.00220.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2018.00220</ArticleId><ArticleId IdType="pmc">PMC6064744</ArticleId><ArticleId IdType="pubmed">30083102</ArticleId></ArticleIdList></Reference><Reference><Citation>Saba R., Gushue S., Huzarewich R.L., Manguiat K., Medina S., Robertson C., Booth S.A. MicroRNA 146a (miR-146a) is over-expressed during prion disease and modulates the innate immune response and the microglial activation state. PLoS One. 2012;7(2):e30832. doi: 10.1371/journal.pone.0030832.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0030832</ArticleId><ArticleId IdType="pmc">PMC3281888</ArticleId><ArticleId IdType="pubmed">22363497</ArticleId></ArticleIdList></Reference><Reference><Citation>Bacot S.M., Lenz P., Frazier-Jessen M.R., Feldman G.M. Activation by prion peptide PrP106-126 induces a NF-kappaB-driven proinflammatory response in human monocyte-derived dendritic cells. J. Leukoc. Biol. 2003;74(1):118&#x2013;125. doi: 10.1189/jlb.1102521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.1102521</ArticleId><ArticleId IdType="pubmed">12832450</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourteele S., Oesterle K., Weinzierl A.O., Paxian S., Riemann M., Schmid R.M., Planz O. Alteration of NF-kappaB activity leads to mitochondrial apoptosis after infection with pathological prion protein. Cell. Microbiol. 2007;9(9):2202&#x2013;2217. doi: 10.1111/j.1462-5822.2007.00950.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1462-5822.2007.00950.x</ArticleId><ArticleId IdType="pmc">PMC2048569</ArticleId><ArticleId IdType="pubmed">17573907</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu G.R., Mu T.C., Gao Z.X., Wang J., Sy M.S., Li C.Y. Prion protein is required for tumor necrosis factor &#x3b1; (TNF&#x3b1;)-triggered nuclear factor KB (NF-KB) signaling and cytokine production. J. Biol. Chem. 2017;292(46):18747&#x2013;18759. doi: 10.1074/jbc.M117.787283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M117.787283</ArticleId><ArticleId IdType="pmc">PMC5704461</ArticleId><ArticleId IdType="pubmed">28900035</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawa A., Wiegand G.W., Cooper J., Margolis R.L., Sharp A.H., Lawler J.F., Jr, Greenamyre J.T., Snyder S.H., Ross C.A. Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. Nat. Med. 1999;5(10):1194&#x2013;1198. doi: 10.1038/13518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/13518</ArticleId><ArticleId IdType="pubmed">10502825</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcora E., Kennedy M.B. The Huntington&#x2019;s disease mutation impairs Huntingtin&#x2019;s role in the transport of NF-KB from the synapse to the nucleus. Hum. Mol. Genet. 2010;19(22):4373&#x2013;4384. doi: 10.1093/hmg/ddq358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq358</ArticleId><ArticleId IdType="pmc">PMC2957321</ArticleId><ArticleId IdType="pubmed">20739295</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin D.D.O., Hayden M.R. Neurodegeneration: Role of repeats in protein clearance. Nature. 2017;545(7652):33&#x2013;34. doi: 10.1038/nature22489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature22489</ArticleId><ArticleId IdType="pubmed">28445458</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexandrov A.I., Serpionov G.V., Kushnirov V.V., Ter-Avanesyan M.D. Wild type huntingtin toxicity in yeast: Implications for the role of amyloid cross-seeding in polyQ diseases. Prion. 2016;10(3):221&#x2013;227. doi: 10.1080/19336896.2016.1176659.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19336896.2016.1176659</ArticleId><ArticleId IdType="pmc">PMC4981198</ArticleId><ArticleId IdType="pubmed">27220690</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatters D.M. Proteome Aggregation patterns under proteostasis stress as signatures for understanding Huntington&#x2019;s Disease. Biophys. J. 2019;116(3):5a. doi: 10.1016/j.bpj.2018.11.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2018.11.054</ArticleId></ArticleIdList></Reference><Reference><Citation>Napolitano M., Zei D., Centonze D., Palermo R., Bernardi G., Vacca A., Calabresi P., Gulino A. NF-kB/NOS cross-talk induced by mitochondrial complex II inhibition: implications for Huntington&#x2019;s disease. Neurosci. Lett. 2008;434(3):241&#x2013;246. doi: 10.1016/j.neulet.2007.09.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2007.09.056</ArticleId><ArticleId IdType="pubmed">18329171</ArticleId></ArticleIdList></Reference><Reference><Citation>Turillazzi E., Neri M., Cerretani D., Cantatore S., Frati P., Moltoni L., Busard&#xf2; F.P., Pomara C., Riezzo I., Fineschi V. Lipid peroxidation and apoptotic response in rat brain areas induced by long-term administration of nandrolone: the mutual crosstalk between ROS and NF-kB. J. Cell. Mol. Med. 2016;20(4):601&#x2013;612. doi: 10.1111/jcmm.12748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.12748</ArticleId><ArticleId IdType="pmc">PMC5125979</ArticleId><ArticleId IdType="pubmed">26828721</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B., Zuo Y.X., Jiang R.T. Astrocyte morphology: Diversity, plasticity, and role in neurological diseases. CNS Neurosci. Ther. 2019;25(6):665&#x2013;673. doi: 10.1111/cns.13123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.13123</ArticleId><ArticleId IdType="pmc">PMC6515705</ArticleId><ArticleId IdType="pubmed">30929313</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P., Du S., Zhou L., Sun Z., Zhuo L.H., He G., Zhao Y., Wu Y., Zhang X. Tetramethylpyrazine-2'O-sodium ferulate provides neuroprotection against neuroinflammation and brain injury in MCAO/R rats by suppressing TLR-4/NF-KB signaling pathway. Pharmacol. Biochem. Behav. 2019;176:33&#x2013;42. doi: 10.1016/j.pbb.2018.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pbb.2018.08.010</ArticleId><ArticleId IdType="pubmed">30171935</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghose J., Sinha M., Das E., Jana N.R., Bhattacharyya N.P. Regulation of miR-146a by RelA/NFkB and p53 in STHdh(Q111)/Hdh(Q111) cells, a cell model of Huntington&#x2019;s disease. PLoS One. 2011;6(8):e23837. doi: 10.1371/journal.pone.0023837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0023837</ArticleId><ArticleId IdType="pmc">PMC3162608</ArticleId><ArticleId IdType="pubmed">21887328</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang K.H., Wu Y.R., Chen C.M. Down-regulation of miR-9* in the peripheral leukocytes of Huntington&#x2019;s disease patients. Orphanet J. Rare Dis. 2017;12(1):185. doi: 10.1186/s13023-017-0742-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-017-0742-x</ArticleId><ArticleId IdType="pmc">PMC5737985</ArticleId><ArticleId IdType="pubmed">29258536</ArticleId></ArticleIdList></Reference><Reference><Citation>Paulson H.L., Shakkottai V.G., Clark H.B., Orr H.T. Polyglutamine spinocerebellar ataxias - from genes to potential treatments. Nat. Rev. Neurosci. 2017;18(10):613&#x2013;626. doi: 10.1038/nrn.2017.92.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn.2017.92</ArticleId><ArticleId IdType="pmc">PMC6420820</ArticleId><ArticleId IdType="pubmed">28855740</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Gu X., Ma Y., Calicchio M.L., Kong D., Teng Y.D., Yu L., Crain A.M., Vartanian T.K., Pasqualini R., Arap W., Libermann T.A., Snyder E.Y., Sidman R.L. Nna1 mediates Purkinje cell dendritic development via lysyl oxidase propeptide and NF-KB signaling. Neuron. 2010;68(1):45&#x2013;60. doi: 10.1016/j.neuron.2010.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.08.013</ArticleId><ArticleId IdType="pmc">PMC4457472</ArticleId><ArticleId IdType="pubmed">20920790</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.H., Lukowicz A., Qu W., Johnson A., Cvetanovic M. Astroglia contribute to the pathogenesis of spinocerebellar ataxia Type 1 (SCA1) in a biphasic, stage-of-disease specific manner. Glia. 2018;66(9):1972&#x2013;1987. doi: 10.1002/glia.23451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23451</ArticleId><ArticleId IdType="pubmed">30043530</ArticleId></ArticleIdList></Reference><Reference><Citation>Mellesmoen A., Sheeler C., Ferro A., Rainwater O., Cvetanovic M. Brain derived neurotrophic factor (BDNF) delays onset of pathogenesis in transgenic mouse model of spinocerebellar ataxia type 1 (SCA1). Front. Cell. Neurosci. 2019;12:509. doi: 10.3389/fncel.2018.00509.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00509</ArticleId><ArticleId IdType="pmc">PMC6348256</ArticleId><ArticleId IdType="pubmed">30718999</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferro A., Qu W., Lukowicz A., Svedberg D., Johnson A., Cvetanovic M. Inhibition of NF-KB signaling in IKK&#x3b2;F/F;LysM Cre mice causes motor deficits but does not alter pathogenesis of Spinocerebellar ataxia type 1. PLoS One. 2018;13(7):e0200013. doi: 10.1371/journal.pone.0200013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0200013</ArticleId><ArticleId IdType="pmc">PMC6033432</ArticleId><ArticleId IdType="pubmed">29975753</ArticleId></ArticleIdList></Reference><Reference><Citation>Koscianska E., Krzyzosiak W.J. Current understanding of the role of microRNAs in spinocerebellar ataxias. Cerebellum Ataxias. 2014;1(1):7. doi: 10.1186/2053-8871-1-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2053-8871-1-7</ArticleId><ArticleId IdType="pmc">PMC4552431</ArticleId><ArticleId IdType="pubmed">26331031</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Stijl R., Withoff S., Verbeek D.S. Spinocerebellar ataxia: miRNAs expose biological pathways underlying pervasive Purkinje cell degeneration. Neurobiol. Dis. 2017;108:148&#x2013;158. doi: 10.1016/j.nbd.2017.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2017.08.003</ArticleId><ArticleId IdType="pubmed">28823930</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarouchlioti C., Parfitt D.A., Li W., Gittings L.M., Cheetham M.E. DNAJ Proteins in neurodegeneration: essential and protective factors. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1738;2018(373):20160534. doi: 10.1098/rstb.2016.0534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rstb.2016.0534</ArticleId><ArticleId IdType="pmc">PMC5717533</ArticleId><ArticleId IdType="pubmed">29203718</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y., Samaco R.C., Gatchel J.R., Thaller C., Orr H.T., Zoghbi H.Y. miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis. Nat. Neurosci. 2008;11(10):1137&#x2013;1139. doi: 10.1038/nn.2183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2183</ArticleId><ArticleId IdType="pmc">PMC2574629</ArticleId><ArticleId IdType="pubmed">18758459</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Lebron E., Liu G., Keiser M., Behlke M.A., Davidson B.L. Altered Purkinje cell miRNA expression and SCA1 pathogenesis. Neurobiol. Dis. 2013;54:456&#x2013;463. doi: 10.1016/j.nbd.2013.01.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.01.019</ArticleId><ArticleId IdType="pmc">PMC3629010</ArticleId><ArticleId IdType="pubmed">23376683</ArticleId></ArticleIdList></Reference><Reference><Citation>Gantier M.P., Stunden H.J., McCoy C.E., Behlke M.A., Wang D., Kaparakis-Liaskos M., Sarvestani S.T., Yang Y.H., Xu D., Corr S.C., Morand E.F., Williams B.R. A miR-19 regulon that controls NF-KB signaling. Nucleic Acids Res. 2012;40(16):8048&#x2013;8058. doi: 10.1093/nar/gks521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks521</ArticleId><ArticleId IdType="pmc">PMC3439911</ArticleId><ArticleId IdType="pubmed">22684508</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutchison E.R., Kawamoto E.M., Taub D.D., Lal A., Abdelmohsen K., Zhang Y., Wood W.H., III, Lehrmann E., Camandola S., Becker K.G., Gorospe M., Mattson M.P. Evidence for miR-181 involvement in neuroinflammatory responses of astrocytes. Glia. 2013;61(7):1018&#x2013;1028. doi: 10.1002/glia.22483.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22483</ArticleId><ArticleId IdType="pmc">PMC4624280</ArticleId><ArticleId IdType="pubmed">23650073</ArticleId></ArticleIdList></Reference><Reference><Citation>Karch C.M., Goate A.M. Alzheimer&#x2019;s disease risk genes and mechanisms of disease pathogenesis. Biol. Psychiatry. 2015;77(1):43&#x2013;51. doi: 10.1016/j.biopsych.2014.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2014.05.006</ArticleId><ArticleId IdType="pmc">PMC4234692</ArticleId><ArticleId IdType="pubmed">24951455</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X.Q., Mobley W.C. Alzheimer disease pathogenesis: insights from molecular and cellular biology studies of oligomeric A&#x3b2; and tau species. Front. Neurosci. 2019;13:659. doi: 10.3389/fnins.2019.00659.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00659</ArticleId><ArticleId IdType="pmc">PMC6598402</ArticleId><ArticleId IdType="pubmed">31293377</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J., Roy S. The physical approximation of APP and BACE-1: A key event in alzheimer&#x2019;s disease pathogenesis. Dev. Neurobiol. 2018;78(3):340&#x2013;347. doi: 10.1002/dneu.22556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dneu.22556</ArticleId><ArticleId IdType="pmc">PMC7336871</ArticleId><ArticleId IdType="pubmed">29106038</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh S.B., Kim M.S., Park S., Son H., Kim S.Y., Kim M.S., Jo D.G., Tak E., Lee J.Y. Clusterin contributes to early stage of Alzheimer&#x2019;s disease pathogenesis. Brain Pathol. 2019;29(2):217&#x2013;231. doi: 10.1111/bpa.12660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12660</ArticleId><ArticleId IdType="pubmed">30295351</ArticleId></ArticleIdList></Reference><Reference><Citation>Pung L., Wang X., Li M., Xue L. The role of APP in Alzheimer&#x2019;s disease. Adv. Alzheimer Dis. 2013;2(02):60. doi: 10.4236/aad.2013.22008.</Citation><ArticleIdList><ArticleId IdType="doi">10.4236/aad.2013.22008</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka M.T., Carson M.J., El Khoury J., Landreth G.E., Brosseron F., Feinstein D.L., Jacobs A.H., Wyss-Coray T., Vitorica J., Ransohoff R.M., Herrup K., Frautschy S.A., Finsen B., Brown G.C., Verkhratsky A., Yamanaka K., Koistinaho J., Latz E., Halle A., Petzold G.C., Town T., Morgan D., Shinohara M.L., Perry V.H., Holmes C., Bazan N.G., Brooks D.J., Hunot S., Joseph B., Deigendesch N., Garaschuk O., Boddeke E., Dinarello C.A., Breitner J.C., Cole G.M., Golenbock D.T., Kummer M.P. Neuroinflammation in Alzheimer&#x2019;s disease. Lancet Neurol. 2015;14(4):388&#x2013;405. doi: 10.1016/S1474-4422(15)70016-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(15)70016-5</ArticleId><ArticleId IdType="pmc">PMC5909703</ArticleId><ArticleId IdType="pubmed">25792098</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka M.T., McManus R.M., Latz E. Inflammasome signalling in brain function and neurodegenerative disease. Nat. Rev. Neurosci. 2018;19(10):610&#x2013;621. doi: 10.1038/s41583-018-0055-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-018-0055-7</ArticleId><ArticleId IdType="pubmed">30206330</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe9;bert S.S., Horr&#xe9; K., Nicola&#xef; L., Bergmans B., Papadopoulou A.S., Delacourte A., De Strooper B. MicroRNA regulation of Alzheimer&#x2019;s Amyloid precursor protein expression. Neurobiol. Dis. 2009;33(3):422&#x2013;428. doi: 10.1016/j.nbd.2008.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2008.11.009</ArticleId><ArticleId IdType="pubmed">19110058</ArticleId></ArticleIdList></Reference><Reference><Citation>Sujeetha P., Cheerian J., Basavaraju P., Moorthi P.V., Anand A.V. The role of epigenetics in Alzheimer&#x2019;s disease. J Geri Ment Health. 2018;5(2):94. doi: 10.4103/jgmh.jgmh_33_17.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jgmh.jgmh_33_17</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Bhattacharjee S., Jones B.M., Hill J., Dua P., Lukiw W.J. Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer&#x2019;s disease (AD) and in primary human neuronal-glial (HNG) cells. Mol. Neurobiol. 2014;50(1):97&#x2013;106. doi: 10.1007/s12035-013-8595-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-013-8595-3</ArticleId><ArticleId IdType="pmc">PMC4038663</ArticleId><ArticleId IdType="pubmed">24293102</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker L., Stefanis L., Attems J. Clinical and neuropathological differences between Parkinson&#x2019;s disease, Parkinson&#x2019;s disease dementia and dementia with Lewy bodies - current issues and future directions. J. Neurochem. 2019;150(5):467&#x2013;474. doi: 10.1111/jnc.14698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14698</ArticleId><ArticleId IdType="pubmed">30892688</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan L., Li Z., Lv Q., Huang W. Rabies virus glycoprotein (RVG29)-linked microRNA-124-loaded polymeric nanoparticles inhibit neuroinflammation in a Parkinson&#x2019;s disease model. Int. J. Pharm. 2019;567:118449. doi: 10.1016/j.ijpharm.2019.118449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijpharm.2019.118449</ArticleId><ArticleId IdType="pubmed">31226473</ArticleId></ArticleIdList></Reference><Reference><Citation>Goes A.T.R., Jesse C.R., Antunes M.S., Lobo Ladd F.V., Lobo Ladd A.A.B., Luchese C., Paroul N., Boeira S.P. Protective role of chrysin on 6-hydroxydopamine-induced neurodegeneration a mouse model of Parkinson&#x2019;s disease: Involvement of neuroinflammation and neurotrophins. Chem. Biol. Interact. 2018;279:111&#x2013;120. doi: 10.1016/j.cbi.2017.10.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbi.2017.10.019</ArticleId><ArticleId IdType="pubmed">29054324</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang X., Wang X., Tuo M., Ma J., Xie A. RAGE and its emerging role in the pathogenesis of Parkinson&#x2019;s disease. Neurosci. Lett. 2018;672:65&#x2013;69. doi: 10.1016/j.neulet.2018.02.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2018.02.049</ArticleId><ArticleId IdType="pubmed">29477598</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassanzadeh K., Rahimmi A. Oxidative stress and neuroinflammation in the story of Parkinson&#x2019;s disease: Could targeting these pathways write a good ending? J. Cell. Physiol. 2018;234(1):23&#x2013;32. doi: 10.1002/jcp.26865.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.26865</ArticleId><ArticleId IdType="pubmed">30078201</ArticleId></ArticleIdList></Reference><Reference><Citation>Asanuma M., Miyazaki I., Ogawa N. Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson&#x2019;s disease. Neurotox. Res. 2003;5(3):165&#x2013;176. doi: 10.1007/BF03033137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03033137</ArticleId><ArticleId IdType="pubmed">12835121</ArticleId></ArticleIdList></Reference><Reference><Citation>Mi&#xf1;ones-Moyano E., Porta S., Escaram&#xed;s G., Rabionet R., Iraola S., Kagerbauer B., Espinosa-Parrilla Y., Ferrer I., Estivill X., Mart&#xed; E. MicroRNA profiling of Parkinson&#x2019;s disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. Hum. Mol. Genet. 2011;20(15):3067&#x2013;3078. doi: 10.1093/hmg/ddr210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr210</ArticleId><ArticleId IdType="pubmed">21558425</ArticleId></ArticleIdList></Reference><Reference><Citation>Harraz M.M., Dawson T.M., Dawson V.L. MicroRNAs in Parkinson&#x2019;s disease. J. Chem. Neuroanat. 2011;42(2):127&#x2013;130. doi: 10.1016/j.jchemneu.2011.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchemneu.2011.01.005</ArticleId><ArticleId IdType="pmc">PMC3163813</ArticleId><ArticleId IdType="pubmed">21295133</ArticleId></ArticleIdList></Reference><Reference><Citation>Correddu D., Leung I.K.H. Targeting mRNA translation in Parkinson&#x2019;s disease. Drug Discov. Today. 2019;24(6):1295&#x2013;1303. doi: 10.1016/j.drudis.2019.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2019.04.003</ArticleId><ArticleId IdType="pubmed">30974176</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n-Nieto J., Uribe M.L., Esteve-Rudd J., Herrero M.T., Campello L. A role for DJ-1 against oxidative stress in the mammalian retina. Neurosci. Lett. 2019;708:134361. doi: 10.1016/j.neulet.2019.134361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2019.134361</ArticleId><ArticleId IdType="pubmed">31276729</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabaria S., Choi D.C., Chaudhuri A.D., Mouradian M.M., Junn E. Inhibition of miR-34b and miR-34c enhances &#x3b1;-synuclein expression in Parkinson&#x2019;s disease. FEBS Lett. 2015;589(3):319&#x2013;325. doi: 10.1016/j.febslet.2014.12.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2014.12.014</ArticleId><ArticleId IdType="pmc">PMC4306645</ArticleId><ArticleId IdType="pubmed">25541488</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao L., Zhu Z., Wu J., Zhang Y., Zhang H., Sun X., Qian C., Wang B., Xie L., Zhang S., Lu G. MicroRNA-124 regulates the expression of p62/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson&#x2019;s disease. FASEB J. 2019;33(7):8648&#x2013;8665. doi: 10.1096/fj.201900363R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201900363R</ArticleId><ArticleId IdType="pubmed">30995872</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S.P., Zhang J.W., Ma J.J., Li X., Qi Y.W., Yang H.Q. The role of miR-146a in MPTP treated mice with Parkinson&#x2019;s disease. Int. J. Clin. Exp. Med. 2019;12(4):3668&#x2013;3676.</Citation></Reference><Reference><Citation>Du S., Deng Y., Yuan H., Sun Y. 2019.</Citation></Reference><Reference><Citation>Ansari M.N., Ganaie M.A., Rehman N.U., Alharthy K.M., Khan T.H., Imam F., Ansari M.A., Al-Harbi N.O., Jan B.L., Sheikh I.A., Hamad A.M. Protective role of Roflumilast against cadmium-induced cardiotoxicity through inhibition of oxidative stress and NF-KB signaling in rats. Saudi Pharm. J. 2019;27(5):673&#x2013;681. doi: 10.1016/j.jsps.2019.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsps.2019.04.002</ArticleId><ArticleId IdType="pmc">PMC6598217</ArticleId><ArticleId IdType="pubmed">31297022</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Wang Y., Yang G.Y. MicroRNAs in cerebral ischemia. Stroke Res. Treat. 2013;2013:276540. doi: 10.1155/2013/276540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/276540</ArticleId><ArticleId IdType="pmc">PMC3606790</ArticleId><ArticleId IdType="pubmed">23533957</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.W., Liu Z., Shi Z.S. Non-Coding RNA in acute ischemic stroke: mechanisms, biomarkers and therapeutic targets. Cell Transplant. 2018;27(12):1763&#x2013;1777. doi: 10.1177/0963689718806818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0963689718806818</ArticleId><ArticleId IdType="pmc">PMC6300774</ArticleId><ArticleId IdType="pubmed">30362372</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang B., Zhong P., Fang L., Wu X., Song Y., Yuan H. miR-183 inhibits microglia activation and expression of inflammatory factors in rats with cerebral ischemia reperfusion via NF-KB signaling pathway. Exp. Ther. Med. 2019;18(4):2540&#x2013;2546. doi: 10.3892/etm.2019.7827.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2019.7827</ArticleId><ArticleId IdType="pmc">PMC6755485</ArticleId><ArticleId IdType="pubmed">31572505</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong H., Cui B., Hao X. MicroRNA-22 alleviates inflammation in ischemic stroke via p38 MAPK pathways. Mol. Med. Rep. 2019;20(1):735&#x2013;744. doi: 10.3892/mmr.2019.10269.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2019.10269</ArticleId><ArticleId IdType="pmc">PMC6580039</ArticleId><ArticleId IdType="pubmed">31115561</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Y., Cui C., Liu X., Wu Q., Hu F., Zhang H., Ma Z., Wang L. Protective role of apocynin via suppression of neuronal autophagy and TLR4/NF-KB signaling pathway in a rat model of traumatic brain injury. Neurochem. Res. 2017;42(11):3296&#x2013;3309. doi: 10.1007/s11064-017-2372-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-017-2372-z</ArticleId><ArticleId IdType="pubmed">28786047</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahimifard M., Maqbool F., Moeini-Nodeh S., Niaz K., Abdollahi M., Braidy N., Nabavi S.M., Nabavi S.F. Targeting the TLR4 signaling pathway by polyphenols: A novel therapeutic strategy for neuroinflammation. Ageing Res. Rev. 2017;36:11&#x2013;19. doi: 10.1016/j.arr.2017.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2017.02.004</ArticleId><ArticleId IdType="pubmed">28235660</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi H., Hua X., Kong D., Stein D., Hua F. Role of Toll-like receptor mediated signaling in traumatic brain injury. 2019.</Citation><ArticleIdList><ArticleId IdType="pubmed">30075158</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayakumar A.R., Tong X.Y., Ruiz-Cordero R., Bregy A., Bethea J.R., Bramlett H.M., Norenberg M.D. Activation of NF-KB mediates astrocyte swelling and brain edema in traumatic brain injury. J. Neurotrauma. 2014;31(14):1249&#x2013;1257. doi: 10.1089/neu.2013.3169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2013.3169</ArticleId><ArticleId IdType="pmc">PMC4108982</ArticleId><ArticleId IdType="pubmed">24471369</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Y., Mahmood A., Chopp M. Current understanding of neuroinflammation after traumatic brain injury and cell-based therapeutic opportunities. Chin. J. Traumatol. 2018;21(3):137&#x2013;151. doi: 10.1016/j.cjtee.2018.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjtee.2018.02.003</ArticleId><ArticleId IdType="pmc">PMC6034172</ArticleId><ArticleId IdType="pubmed">29764704</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Y., Cui Y., Gao J.L., Li M.H., Li R., Jiang X.H., Tian Y.X., Wang K.J., Cui C.M., Cui J.Z. Resveratrol attenuates neuronal autophagy and inflammatory injury by inhibiting the TLR4/NF-KB signaling pathway in experimental traumatic brain injury. Int. J. Mol. Med. 2016;37(4):921&#x2013;930. doi: 10.3892/ijmm.2016.2495.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2016.2495</ArticleId><ArticleId IdType="pmc">PMC4790669</ArticleId><ArticleId IdType="pubmed">26936125</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong L., Yao Y., Xia Y., Liang X., Ni Y., Yang J. Osthole alleviates inflammation by down-regulating NF-KB signaling pathway in traumatic brain injury. Immunopharmacol. Immunotoxicol. 2019;41(2):349&#x2013;360. doi: 10.1080/08923973.2019.1608560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08923973.2019.1608560</ArticleId><ArticleId IdType="pubmed">31056982</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L., Sun T., Liu Z., Chen X., Zhao L., Qu G., Li Q. Traumatic brain injury dysregulates microRNAs to modulate cell signaling in rat hippocampus. PLoS One. 2014;9(8):e103948. doi: 10.1371/journal.pone.0103948.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0103948</ArticleId><ArticleId IdType="pmc">PMC4121204</ArticleId><ArticleId IdType="pubmed">25089700</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W.X., Visavadiya N.P., Pandya J.D., Nelson P.T., Sullivan P.G., Springer J.E. Mitochondria-associated microRNAs in rat hippocampus following traumatic brain injury. Exp. Neurol. 2015;265:84&#x2013;93. doi: 10.1016/j.expneurol.2014.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2014.12.018</ArticleId><ArticleId IdType="pmc">PMC4346439</ArticleId><ArticleId IdType="pubmed">25562527</ArticleId></ArticleIdList></Reference><Reference><Citation>Su X., Ye Y., Yang Y., Zhang K., Bai W., Chen H., Kang E., Kong C., He X. The Effect of SPTLC2 on promoting neuronal apoptosis is alleviated by MiR-124-3p through TLR4 signalling pathway. Neurochem. Res. 2019;44(9):2113&#x2013;2122. doi: 10.1007/s11064-019-02849-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-019-02849-7</ArticleId><ArticleId IdType="pubmed">31372925</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee B.H., Kim Y.K. The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment. Psychiatry Investig. 2010;7(4):231&#x2013;235. doi: 10.4306/pi.2010.7.4.231.</Citation><ArticleIdList><ArticleId IdType="doi">10.4306/pi.2010.7.4.231</ArticleId><ArticleId IdType="pmc">PMC3022308</ArticleId><ArticleId IdType="pubmed">21253405</ArticleId></ArticleIdList></Reference><Reference><Citation>Caviedes A., Lafourcade C., Soto C., Wyneken U. BDNF/NF-KB signaling in the neurobiology of depression. Curr. Pharm. Des. 2017;23(21):3154&#x2013;3163. doi: 10.2174/1381612823666170111141915.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612823666170111141915</ArticleId><ArticleId IdType="pubmed">28078988</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C.H., Zhang G.Z., Li B., Li M., Woelfer M., Walter M., Wang L. Role of inflammation in depression relapse. J. Neuroinflammation. 2019;16(1):90. doi: 10.1186/s12974-019-1475-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-019-1475-7</ArticleId><ArticleId IdType="pmc">PMC6472093</ArticleId><ArticleId IdType="pubmed">30995920</ArticleId></ArticleIdList></Reference><Reference><Citation>Koo J.W., Russo S.J., Ferguson D., Nestler E.J., Duman R.S. Nuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc. Natl. Acad. Sci. USA. 2010;107(6):2669&#x2013;2674. doi: 10.1073/pnas.0910658107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0910658107</ArticleId><ArticleId IdType="pmc">PMC2823860</ArticleId><ArticleId IdType="pubmed">20133768</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang C.Z., Zhang D.F., Yang J.T., Liu Q.H., Wang Y.R., Wang W.S. Overexpression of microRNA-301b accelerates hippocampal microglia activation and cognitive impairment in mice with depressive-like behavior through the NF-KB signaling pathway. Cell Death Dis. 2019;10(4):316. doi: 10.1038/s41419-019-1522-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-1522-4</ArticleId><ArticleId IdType="pmc">PMC6453902</ArticleId><ArticleId IdType="pubmed">30962417</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung Y.Y., Wu M.K., Tsai M.C., Huang Y.L., Kang H.Y. Aberrant Expression of Intracellular let-7e, miR-146a, and miR-155 correlates with severity of depression in patients with major depressive disorder and is ameliorated after antidepressant treatment. Cells. 2019;8(7):647. doi: 10.3390/cells8070647.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8070647</ArticleId><ArticleId IdType="pmc">PMC6678487</ArticleId><ArticleId IdType="pubmed">31252530</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng J., Wang M., Li M., Yang J., Jia J., Liu L., Zhou J., Zhang C., Wang X. Serum miR-221-3p as a new potential biomarker for depressed mood in perioperative patients. Brain Res. 2019;1720:146296. doi: 10.1016/j.brainres.2019.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2019.06.015</ArticleId><ArticleId IdType="pubmed">31211948</ArticleId></ArticleIdList></Reference><Reference><Citation>Vezzani A., Aronica E., Mazarati A., Pittman Q.J. Epilepsy and brain inflammation. Exp. Neurol. 2013;244:11&#x2013;21. doi: 10.1016/j.expneurol.2011.09.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2011.09.033</ArticleId><ArticleId IdType="pubmed">21985866</ArticleId></ArticleIdList></Reference><Reference><Citation>Rana A., Musto A.E. The role of inflammation in the development of epilepsy. J. Neuroinflammation. 2018;15(1):144. doi: 10.1186/s12974-018-1192-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-018-1192-7</ArticleId><ArticleId IdType="pmc">PMC5952578</ArticleId><ArticleId IdType="pubmed">29764485</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G., Bauer S., Nowak M., Norwood B., Tackenberg B., Rosenow F., Knake S., Oertel W.H., Hamer H.M. Cytokines and epilepsy. Seizure. 2011;20(3):249&#x2013;256. doi: 10.1016/j.seizure.2010.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.seizure.2010.12.005</ArticleId><ArticleId IdType="pubmed">21216630</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowley S., Patel M. Mitochondrial involvement and oxidative stress in temporal lobe epilepsy. Free Radic. Biol. Med. 2013;62:121&#x2013;131. doi: 10.1016/j.freeradbiomed.2013.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2013.02.002</ArticleId><ArticleId IdType="pmc">PMC4043127</ArticleId><ArticleId IdType="pubmed">23411150</ArticleId></ArticleIdList></Reference><Reference><Citation>Vezzani A., French J., Bartfai T., Baram T.Z. The role of inflammation in epilepsy. Nat. Rev. Neurol. 2011;7(1):31&#x2013;40. doi: 10.1038/nrneurol.2010.178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2010.178</ArticleId><ArticleId IdType="pmc">PMC3378051</ArticleId><ArticleId IdType="pubmed">21135885</ArticleId></ArticleIdList></Reference><Reference><Citation>Devinsky O., Vezzani A., Najjar S., De Lanerolle N.C., Rogawski M.A. Glia and epilepsy: excitability and inflammation. Trends Neurosci. 2013;36(3):174&#x2013;184. doi: 10.1016/j.tins.2012.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2012.11.008</ArticleId><ArticleId IdType="pubmed">23298414</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimada T., Takemiya T., Sugiura H., Yamagata K. Role of inflammatory mediators in the pathogenesis of epilepsy. Mediators Inflamm. 2014;2014:901902. doi: 10.1155/2014/901902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/901902</ArticleId><ArticleId IdType="pmc">PMC4147258</ArticleId><ArticleId IdType="pubmed">25197169</ArticleId></ArticleIdList></Reference><Reference><Citation>Somade O.T., Ajayi B.O., Adeyi O.E., Aina B.O., David B. O., Sodiya I.D. 2019.</Citation></Reference><Reference><Citation>Aronica E., Fluiter K., Iyer A., Zurolo E., Vreijling J., van Vliet E.A., Baayen J.C., Gorter J.A. Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. Eur. J. Neurosci. 2010;31(6):1100&#x2013;1107. doi: 10.1111/j.1460-9568.2010.07122.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2010.07122.x</ArticleId><ArticleId IdType="pubmed">20214679</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M.M., Li X.M., Zheng X.P., Yu J.T., Tan L. MicroRNAs dysregulation in epilepsy. Brain Res. 2014;1584:94&#x2013;104. doi: 10.1016/j.brainres.2013.09.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2013.09.049</ArticleId><ArticleId IdType="pubmed">24096213</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsharafi W., Xiao B. Dynamic expression of microRNAs (183, 135a, 125b, 128, 30c and 27a) in the rat pilocarpine model and temporal lobe epilepsy patients. CNS Neurol. Disord. Drug Targets. 2015;14(8):1096&#x2013;1102. doi: 10.2174/1871527314666150317225945.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871527314666150317225945</ArticleId><ArticleId IdType="pubmed">25801837</ArticleId></ArticleIdList></Reference><Reference><Citation>Henshall D.C., Hamer H.M., Pasterkamp R.J., Goldstein D.B., Kjems J., Prehn J.H.M., Schorge S., Lamottke K., Rosenow F. MicroRNAs in epilepsy: pathophysiology and clinical utility. Lancet Neurol. 2016;15(13):1368&#x2013;1376. doi: 10.1016/S1474-4422(16)30246-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(16)30246-0</ArticleId><ArticleId IdType="pubmed">27839653</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang W.S., Zhu L. MiR-134 expression and changes in inflammatory cytokines of rats with epileptic seizures. Eur. Rev. Med. Pharmacol. Sci. 2018;22(11):3479&#x2013;3484.</Citation><ArticleIdList><ArticleId IdType="pubmed">29917202</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonkoly E., Pivarcsi A. microRNAs in inflammation. Int. Rev. Immunol. 2009;28(6):535&#x2013;561. doi: 10.3109/08830180903208303.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08830180903208303</ArticleId><ArticleId IdType="pubmed">19954362</ArticleId></ArticleIdList></Reference><Reference><Citation>Rippo M.R., Olivieri F., Monsurr&#xf2; V., Prattichizzo F., Albertini M.C., Procopio A.D. MitomiRs in human inflamm-aging: a hypothesis involving miR-181a, miR-34a and miR-146a. Exp. Gerontol. 2014;56:154&#x2013;163. doi: 10.1016/j.exger.2014.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2014.03.002</ArticleId><ArticleId IdType="pubmed">24607549</ArticleId></ArticleIdList></Reference><Reference><Citation>Ping H. P.; Feng Bo, T.; Li, L.; Nan, H. Y.; Hong, Z. IL-1&#x3b2;/NF-kb signaling promotes colorectal cancer cell growth through miR-181a/PTEN axis. Arch. Biochem. Biophys. 2016;604:20&#x2013;26. doi: 10.1016/j.abb.2016.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2016.06.001</ArticleId><ArticleId IdType="pubmed">27264420</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivastava A., Dixit A.B., Banerjee J., Tripathi M., Sarat Chandra P. Role of inflammation and its miRNA based regulation in epilepsy: Implications for therapy. Clin. Chim. Acta. 2016;452:1&#x2013;9. doi: 10.1016/j.cca.2015.10.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2015.10.023</ArticleId><ArticleId IdType="pubmed">26506013</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu A.H., Wu Y.T., Wang Y.P. MicroRNA-129-5p inhibits the development of autoimmune encephalomyelitis-related epilepsy by targeting HMGB1 through the TLR4/NF-kB signaling pathway. Brain Res. Bull. 2017;132:139&#x2013;149. doi: 10.1016/j.brainresbull.2017.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2017.05.004</ArticleId><ArticleId IdType="pubmed">28528202</ArticleId></ArticleIdList></Reference><Reference><Citation>Srinivasan M., Lahiri D.K. Significance of NF-KB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer&#x2019;s disease and multiple sclerosis. Expert Opin. Ther. Targets. 2015;19(4):471&#x2013;487. doi: 10.1517/14728222.2014.989834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14728222.2014.989834</ArticleId><ArticleId IdType="pmc">PMC5873291</ArticleId><ArticleId IdType="pubmed">25652642</ArticleId></ArticleIdList></Reference><Reference><Citation>Karunaweera N., Raju R., Gyengesi E., M&#xfc;nch G. Plant polyphenols as inhibitors of NF-KB induced cytokine production-a potential anti-inflammatory treatment for Alzheimer&#x2019;s disease? Front. Mol. Neurosci. 2015;8:24. doi: 10.3389/fnmol.2015.00024.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2015.00024</ArticleId><ArticleId IdType="pmc">PMC4468843</ArticleId><ArticleId IdType="pubmed">26136655</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo E.J., Fischer N., Efferth T. Phytochemicals as inhibitors of NF-KB for treatment of Alzheimer&#x2019;s disease. Pharmacol. Res. 2018;129:262&#x2013;273. doi: 10.1016/j.phrs.2017.11.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2017.11.030</ArticleId><ArticleId IdType="pubmed">29179999</ArticleId></ArticleIdList></Reference><Reference><Citation>Santa-Cec&#xed;lia F.V., Socias B., Ouidja M.O., Sepulveda-Diaz J.E., Acu&#xf1;a L., Silva R.L., Michel P.P., Del-Bel E., Cunha T.M., Raisman-Vozari R. Doxycycline suppresses microglial activation by inhibiting the p38 MAPK and NF-kB signaling pathways. Neurotox. Res. 2016;29(4):447&#x2013;459. doi: 10.1007/s12640-015-9592-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-015-9592-2</ArticleId><ArticleId IdType="pubmed">26745968</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing H., Wang S., Wang M., Fu W., Zhang C., Xu D. Isobavachalcone attenuates mptp-induced Parkinson&#x2019;s Disease in mice by inhibition of microglial activation through NF-KB pathway. PLoS One. 2017;12(1):e0169560. doi: 10.1371/journal.pone.0169560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0169560</ArticleId><ArticleId IdType="pmc">PMC5217967</ArticleId><ArticleId IdType="pubmed">28060896</ArticleId></ArticleIdList></Reference><Reference><Citation>Subedi L., Lee J.H., Yumnam S., Ji E., Kim S.Y. Anti-inflammatory effect of sulforaphane on lps-activated microglia potentially through JNK/AP-1/NF-KB inhibition and Nrf2/HO-1 Activation. Cells. 2019;8(2):194. doi: 10.3390/cells8020194.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8020194</ArticleId><ArticleId IdType="pmc">PMC6406309</ArticleId><ArticleId IdType="pubmed">30813369</ArticleId></ArticleIdList></Reference><Reference><Citation>Majdi F., Taheri F., Salehi P., Motaghinejad M., Safari S. Cannabinoids &#x394;9-tetrahydrocannabinol and cannabidiol may be effective against methamphetamine induced mitochondrial dysfunction and inflammation by modulation of Toll-like type-4(Toll-like 4) receptors and NF-KB signaling. Med. Hypotheses. 2019;133:109371. doi: 10.1016/j.mehy.2019.109371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2019.109371</ArticleId><ArticleId IdType="pubmed">31465975</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu H., Le W.D., Xie Y.Y., Wang X.P. Current therapy of drugs in amyotrophic lateral sclerosis. Curr. Neuropharmacol. 2016;14(4):314&#x2013;321. doi: 10.2174/1570159X14666160120152423.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159X14666160120152423</ArticleId><ArticleId IdType="pmc">PMC4876587</ArticleId><ArticleId IdType="pubmed">26786249</ArticleId></ArticleIdList></Reference><Reference><Citation>Crisafulli S.G., Brajkovic S., Cipolat Mis M.S., Parente V., Corti S. Therapeutic strategies under development targeting inflammatory mechanisms in amyotrophic lateral sclerosis. Mol. Neurobiol. 2018;55(4):2789&#x2013;2813. doi: 10.1007/s12035-017-0532-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0532-4</ArticleId><ArticleId IdType="pubmed">28455693</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z., Fu J., Li S., Li Z. Neuroprotective effects of genistein in a sod1-g93a transgenic mouse model of amyotrophic lateral sclerosis. J. Neuroimmune Pharmacol. 2019;14(4):688&#x2013;696. doi: 10.1007/s11481-019-09866-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-019-09866-x</ArticleId><ArticleId IdType="pubmed">31321663</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun Y.C., Jeong S.G., Kim S.H., Cho G.W. Reduced sirtuin 1/adenosine monophosphate-activated protein kinase in amyotrophic lateral sclerosis patient-derived mesenchymal stem cells can be restored by resveratrol. J. Tissue Eng. Regen. Med. 2019;13(1):110&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pubmed">30479062</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai Y., Li Q., Yang J., Zhou X., Yin X., Zhao D. p75(NTR) activation of NF-kappaB is involved in PrP106-126-induced apoptosis in mouse neuroblastoma cells. Neurosci. Res. 2008;62(1):9&#x2013;14. doi: 10.1016/j.neures.2008.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2008.05.004</ArticleId><ArticleId IdType="pubmed">18602709</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J., Kim J., Min D.Y., Jung E., Lim Y., Shin S.Y., Lee Y.H. Inhibition of TNF&#x3b1;-induced interleukin-6 gene expression by barley (Hordeum vulgare) ethanol extract in BV-2 microglia. Genes Genomics. 2019;41(5):557&#x2013;566. doi: 10.1007/s13258-018-00781-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13258-018-00781-8</ArticleId><ArticleId IdType="pubmed">30796706</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Previn R., Lu L., Liao R.F., Jin Y., Wang R.K. Crocin, a natural product attenuates lipopolysaccharide-induced anxiety and depressive-like behaviors through suppressing NF-kB and NLRP3 signaling pathway. Brain Res. Bull. 2018;142:352&#x2013;359. doi: 10.1016/j.brainresbull.2018.08.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2018.08.021</ArticleId><ArticleId IdType="pubmed">30179677</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H., Zhang F., Guan X. Baicalin reverse depressive-like behaviors through regulation SIRT1-NF-kB signaling pathway in olfactory bulbectomized rats. Phytother. Res. 2019;33(5):1480&#x2013;1489. doi: 10.1002/ptr.6340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.6340</ArticleId><ArticleId IdType="pubmed">30848526</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Agamy D.S., El-Harbi K.M., Khoshhal S., Ahmed N., Elkablawy M.A., Shaaban A.A., Abo-Haded H.M. Pristimerin protects against doxorubicin-induced cardiotoxicity and fibrosis through modulation of Nrf2 and MAPK/NF-kB signaling pathways. Cancer Manag. Res. 2018;11:47&#x2013;61. doi: 10.2147/CMAR.S186696.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CMAR.S186696</ArticleId><ArticleId IdType="pmc">PMC6304079</ArticleId><ArticleId IdType="pubmed">30588110</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu S., Tang S., Su F. Dioscin inhibits ischemic stroke-induced inflammation through inhibition of the TLR4/MyD88/NF-KB signaling pathway in a rat model. Mol. Med. Rep. 2018;17(1):660&#x2013;666.</Citation><ArticleIdList><ArticleId IdType="pubmed">29115455</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X., Zeng H., Wang Q., Yu Q., Wu J., Feng Y., Deng P., Zhang H. Glycyrrhizin ameliorates inflammatory pain by inhibiting microglial activation-mediated inflammatory response via blockage of the HMGB1-TLR4-NF-kB pathway. Exp. Cell Res. 2018;369(1):112&#x2013;119. doi: 10.1016/j.yexcr.2018.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2018.05.012</ArticleId><ArticleId IdType="pubmed">29763588</ArticleId></ArticleIdList></Reference><Reference><Citation>Luan L., Cao L., Zhu L., Sun J. Diosmetin ameliorates cerebral ischemia/reperfusion injury in pc12 cells through nuclear factor-kB (NF-kB) and nuclear factor erythroid 2-related factor/heme oxygenase-1 (Nrf 2/HO-1) Pathway. Curr. Top. Nutraceutical Res. 2019;17(3):322&#x2013;328. doi: 10.37290/ctnr2641-452X.17:322-328.</Citation><ArticleIdList><ArticleId IdType="doi">10.37290/ctnr2641-452X.17:322-328</ArticleId></ArticleIdList></Reference><Reference><Citation>Nan D., Jin H., Deng J., Yu W., Liu R., Sun W., Huang Y. Cilostazol ameliorates ischemia/reperfusion-induced tight junction disruption in brain endothelial cells by inhibiting endoplasmic reticulum stress. FASEB J. 2019;33(9):10152&#x2013;10164. doi: 10.1096/fj.201900326R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201900326R</ArticleId><ArticleId IdType="pubmed">31184927</ArticleId></ArticleIdList></Reference><Reference><Citation>Gugliandolo E., D&#x2019;Amico R., Cordaro M., Fusco R., Siracusa R., Crupi R., Impellizzeri D., Cuzzocrea S., Di Paola R. Neuroprotective effect of artesunate in experimental model of traumatic brain injury. Front. Neurol. 2018;9:590. doi: 10.3389/fneur.2018.00590.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00590</ArticleId><ArticleId IdType="pmc">PMC6079305</ArticleId><ArticleId IdType="pubmed">30108544</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai W., Wang H., Fang J., Zhu Y., Zhou J., Wang X., Zhou Y., Zhou M. Curcumin provides neuroprotection in model of traumatic brain injury via the Nrf2-ARE signaling pathway. Brain Res. Bull. 2018;140:65&#x2013;71. doi: 10.1016/j.brainresbull.2018.03.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2018.03.020</ArticleId><ArticleId IdType="pubmed">29626606</ArticleId></ArticleIdList></Reference><Reference><Citation>Caglayan B., Kilic E., Dalay A., Altunay S., Tuzcu M., Erten F., Orhan C., Gunal M.Y., Yulug B., Juturu V., Sahin K. Allyl isothiocyanate attenuates oxidative stress and inflammation by modulating Nrf2/HO-1 and NF-KB pathways in traumatic brain injury in mice. Mol. Biol. Rep. 2019;46(1):241&#x2013;250. doi: 10.1007/s11033-018-4465-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-018-4465-4</ArticleId><ArticleId IdType="pubmed">30406889</ArticleId></ArticleIdList></Reference><Reference><Citation>Vigont V., Gusev K., Kaznacheyeva E. EVP4593 Compound Decreases abnormal store-operated calcium entry in ipscs-based model of Huntington&#x2019;s Disease. Biophysical. 2018;114(3):285a&#x2013;286a. doi: 10.1016/j.bpj.2017.11.1638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2017.11.1638</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickenberg A.K., Hagai E.L., Eyal E. 2018.</Citation></Reference><Reference><Citation>Pandey M., Rajamma U. Huntington&#x2019;s disease: the coming of age. J. Genet. 2018;97(3):649&#x2013;664. doi: 10.1007/s12041-018-0957-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12041-018-0957-1</ArticleId><ArticleId IdType="pubmed">30027901</ArticleId></ArticleIdList></Reference><Reference><Citation>Mestre T.A. Recent advances in the therapeutic development for Huntington disease. Parkinsonism Relat. Disord. 2019;59:125&#x2013;130. doi: 10.1016/j.parkreldis.2018.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2018.12.003</ArticleId><ArticleId IdType="pubmed">30616867</ArticleId></ArticleIdList></Reference><Reference><Citation>Denis H.L., Lauruol F., Cicchetti F. Are immunotherapies for Huntington&#x2019;s disease a realistic option? Mol. Psychiatry. 2019;24(3):364&#x2013;377. doi: 10.1038/s41380-018-0021-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-018-0021-9</ArticleId><ArticleId IdType="pubmed">29487401</ArticleId></ArticleIdList></Reference><Reference><Citation>Kataria R., Sobarzo-Sanchez E., Khatkar A. Role of morin in neurodegenerative diseases: a review. Curr. Top. Med. Chem. 2018;18(11):901&#x2013;907. doi: 10.2174/1568026618666180711153416.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568026618666180711153416</ArticleId><ArticleId IdType="pubmed">29992884</ArticleId></ArticleIdList></Reference><Reference><Citation>Provost P. MicroRNAs as a molecular basis for mental retardation, Alzheimer&#x2019;s and prion diseases. Brain Res. 2010;1338:58&#x2013;66. doi: 10.1016/j.brainres.2010.03.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2010.03.069</ArticleId><ArticleId IdType="pmc">PMC2896967</ArticleId><ArticleId IdType="pubmed">20347722</ArticleId></ArticleIdList></Reference><Reference><Citation>Satoh J. Molecular network of microRNA targets in Alzheimer&#x2019;s disease brains. Exp. Neurol. 2012;235(2):436&#x2013;446. doi: 10.1016/j.expneurol.2011.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2011.09.003</ArticleId><ArticleId IdType="pubmed">21945006</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva F.C., Iop R.D., Vietta G.G., Kair D.A., Gutierres Filho P.J., de Alvarenga J.G., da Silva R. microRNAs involved in Parkinson&#x2019;s disease: A systematic review. Mol. Med. Rep. 2016;14(5):4015&#x2013;4022. doi: 10.3892/mmr.2016.5759.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2016.5759</ArticleId><ArticleId IdType="pubmed">27666518</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai M., Abe K., Okamoto K., Itoyama Y. Identification of alternative splicing forms of GLT-1 mRNA in the spinal cord of amyotrophic lateral sclerosis patients. Neurosci. Lett. 1998;244(3):165&#x2013;168. doi: 10.1016/S0304-3940(98)00158-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0304-3940(98)00158-X</ArticleId><ArticleId IdType="pubmed">9593515</ArticleId></ArticleIdList></Reference><Reference><Citation>Trotti D., Rolfs A., Danbolt N.C., Brown R.H., Jr, Hediger M.A. SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter. Nat. Neurosci. 1999;2(5):427&#x2013;433. doi: 10.1038/8091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/8091</ArticleId><ArticleId IdType="pubmed">10321246</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Sayana P., Zhang X., Le W. Genetics of amyotrophic lateral sclerosis: an update. Mol. Neurodegener. 2013;8(1):28. doi: 10.1186/1750-1326-8-28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-8-28</ArticleId><ArticleId IdType="pmc">PMC3766231</ArticleId><ArticleId IdType="pubmed">23941283</ArticleId></ArticleIdList></Reference><Reference><Citation>Souza P.V., Pinto W.B., Oliveira A.S. C9orf72-related disorders: expanding the clinical and genetic spectrum of neurodegenerative diseases. Arq. Neuropsiquiatr. 2015;73(3):246&#x2013;256. doi: 10.1590/0004-282X20140229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0004-282X20140229</ArticleId><ArticleId IdType="pubmed">25807132</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann S., Zerr I., Weber T., Poser S., Kretzschmar H., Hunsmann G., Bodemer W. Prion disease associated with a novel nine octapeptide repeat insertion in the PRNP gene. Brain Res. Mol. Brain Res. 1995;34(1):173&#x2013;176. doi: 10.1016/0169-328X(95)00175-R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0169-328X(95)00175-R</ArticleId><ArticleId IdType="pubmed">8750875</ArticleId></ArticleIdList></Reference><Reference><Citation>Baybutt H., Manson J. Characterisation of two promoters for prion protein (PrP) gene expression in neuronal cells. Gene. 1997;184(1):125&#x2013;131. doi: 10.1016/S0378-1119(96)00600-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0378-1119(96)00600-2</ArticleId><ArticleId IdType="pubmed">9016962</ArticleId></ArticleIdList></Reference><Reference><Citation>Boakye P.A., Olechowski C., Rashiq S., Verrier M.J., Kerr B., Witmans M., Baker G., Joyce A., Dick B.D. A critical review of neurobiological factors involved in the interactions between chronic pain, depression, and sleep disruption. Clin. J. Pain. 2016;32(4):327&#x2013;336. doi: 10.1097/AJP.0000000000000260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AJP.0000000000000260</ArticleId><ArticleId IdType="pubmed">26035521</ArticleId></ArticleIdList></Reference><Reference><Citation>Burak K., Lamoureux L., Boese A., Majer A., Saba R., Niu Y., Frost K., Booth S.A. MicroRNA-16 targets mRNA involved in neurite extension and branching in hippocampal neurons during presymptomatic prion disease. Neurobiol. Dis. 2018;112:1&#x2013;13. doi: 10.1016/j.nbd.2017.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2017.12.011</ArticleId><ArticleId IdType="pubmed">29277556</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>